Joe R Delaney

Associate Professor at the Medical University of South Carolina, cancer genetics, translational oncology, bioinformatics, science

[Joe R Delaney @JoeRDelaney1]

For those who would like a free scientific graphing tool, I recently released a free online app: Spectrum Data Plotter. I made this previously available for my own students and staff, but now I am releasing online for anyone in the world to use
https://t.co/r4UNcvYoqm

[Joe R Delaney @JoeRDelaney1]

Never before have I seen evidence for something living* (*resting) across tens of thousands of years. Amazing basic science https://t.co/5d6WBFY6JR

[Joe R Delaney @JoeRDelaney1]

Triploproficiency affects human disease. Oncogene-like addiction to aneuploidy in human cancers https://t.co/s8XVzUU60r

[Joe R Delaney @JoeRDelaney1]

We're honored our new DP2 grant will fund our research into targeting aneuploid pathways in cancer. Crazy scientifically, but if it works, a new generation of drugs will come. Cancer is hard. Science must match its challenge @NIH_CommonFund #NIHHighRisk @muschollings

[Joe R Delaney @JoeRDelaney1]

An exciting article improving our understanding of immunotherapy in ovarian cancer

Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis https://t.co/w60eCElT41

[Joe R Delaney @JoeRDelaney1]

Feeding dogs once daily is associated with fewer disease events than dogs fed 2-3x daily, even when weight, breed and other factors are controlled for https://t.co/LLOkDzonTL

[Joe R Delaney @JoeRDelaney1]

Great to see well-controlled diet studies completing. Interpretations are currently limited, but its a big step forward https://t.co/drehqL9Lbo

[Joe R Delaney @JoeRDelaney1]

SWAN pathway-network identification of common aneuploidy-based oncogenic drivers https://t.co/C2bYXDX9u7

[Joe R Delaney @JoeRDelaney1]

Our click-to-run pathway analysis software is now released at Nucleic Acids Research. Try it out! Any gene-centric data work great with SWAN #research #software. You may be surprised what new findings you come across https://t.co/3oRof7CHvQ

[Joe R Delaney @JoeRDelaney1]

Combination Of Autophagy Selective Therapeutics (COAST) is now an active clinical trial, NCT05036226. Thank you $ donors! Let's save some lives

[Joe R Delaney @JoeRDelaney1]

Interesting peptide-based strategy to directly target the critical autophagy proteins LC3A and LC3B.

Directed evolution of cyclic peptides for inhibition of autophagy - now published in Chemical Science https://t.co/gxA4SHG5H4

[Joe R Delaney @JoeRDelaney1]

Aneuploidy and copy-number variants may be more prognostic for overall survival than other clinical features
https://t.co/b5DA0Ej6Wd via @JAMANetworkOpen part of @JAMANetwork

[Joe R Delaney @JoeRDelaney1]

New promising findings regarding safety and potential efficacy of the off-patent drug nelfinavir in advanced cervical cancer https://t.co/8fVMsTdjGt

[Joe R Delaney @JoeRDelaney1]

Pleased to announce our release of SWAN pathway analysis: https://t.co/MYTSHPo4Jj #bioRxiv If you use any gene-centric big data, give it a shot- we'd love to hear how it works for you. Zero programming/downloads needed for users